Dendritic Cell Tumor Fusion
Neoplasms, Neuroepithelial
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityCell therapyPhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Neoplasms, Neuroepithelial cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Interleukin-12 Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 1/2 | CCC |
Zoladex St. Jude Children's Research Hospital | Phase 1 | CC |
Sonidegib St. Jude Children's Research Hospital | Phase 1 | CC |
Letrozole St. Jude Children's Research Hospital | Phase 1 | CC |
Ribociclib St. Jude Children's Research Hospital | Phase 1 | CC |
View all 9 →
Same molecule, other indications
Dendritic Cell Tumor Fusion is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →